Cargando…
THU319 Hyperglycemia Associated With Raynaud’s Phenomenon And Liver Dysfunction After COVID-19 Vaccination In Type 1 Diabetes
Disclosure: Z. Zavgorodneva: None. C. Zhang: None. S. Siddiqui: None. T. Zahedi: None. Introduction: The association of COVID-19 vaccinations and the incremental changes in glycemic control is still debatable. Some studies found the impacts of vaccination on glucose variations ((1)), while other inv...
Autores principales: | Zavgorodneva, Zhanna, Zhang, Calvin, Siddiqui, Samrah, Zahedi, Tooraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553745/ http://dx.doi.org/10.1210/jendso/bvad114.753 |
Ejemplares similares
-
Hyperglycemia Associated With Raynaud Phenomenon and Liver Dysfunction After COVID-19 Vaccination in Type 1 Diabetes Mellitus
por: Zavgorodneva, Zhanna, et al.
Publicado: (2023) -
THU372 Finasteride Induced Hyperglycemia
por: Bose, Vivek, et al.
Publicado: (2023) -
THU354 Enfortumab Vedotin Induced Refractory Hyperglycemia
por: Hussein, Marwah, et al.
Publicado: (2023) -
THU385 Refractory Hyperglycemia As Main Presenting Symptom In A Patient With Acromegaly
por: Rave, Talia, et al.
Publicado: (2023) -
THU289 Hemichorea-Hemiballismus Syndrome Secondary To Steroid Induced Hyperglycemia In A Nondiabetic
por: Krishnaraju, Ellil, et al.
Publicado: (2023)